COMMUNIQUÉS West-GlobeNewswire

Precipio Announces Q1-2026 Shareholder Update Call
06/05/2026
Conference Call will be held on May 18th, 2026, at 5:00 PM EST NEW HAVEN, Conn., May 06, 2026 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) , will be hosting its Q1-2026 [...]
Sanuwave Will Host a Conference Call on May 13, 2026 at 8:30 AM (ET) to Present Q1 2026 Financial Results
06/05/2026
EDEN PRAIRIE, Minn., May 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live [...]
argenx Announces Results of Annual General Meeting and Board of Directors’ Appointment of Karen Massey as Chief Executive Officer
06/05/2026
Leadership transition marks next evolution of growth May 6, 2026 Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology innovator committed to improving the lives of people suffering [...]
Vireo Growth Inc. to Release First Quarter Results on May 12, 2026
06/05/2026
MINNEAPOLIS, May 06, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF), today announced that it will release its financial results for its first quarter ended March 31, 2026 [...]
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
06/05/2026
Phase 1a interim data for ongoing CTIM-76 (CLDN6 x CD3) trial expected in June 2026 Phase 1a interim data for ongoing CT-95 (MSLN x CD3) trial expected in September 2026 Phase 1 initiation for CT-202 (Nectin-4 x CD3) [...]
Alpha Honey Gummies Claims Evaluated: The AlphaHoney Male Enhancement Ingredients for Virility-Enhancing Performance Support
06/05/2026
How Muira Puama, Maca, Ashwagandha, L-Arginine, and Tribulus Terrestris Work in the AlphaHoney Male Performance Gummy Formula for Libido, Testosterone Support, and Circulation in 2026 Largo, FL, May 06, 2026 (GLOBE [...]
Rapid Micro Biosystems to Announce First Quarter 2026 Financial Results on May 13, 2026
06/05/2026
LEXINGTON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to [...]
Monthly information on share capital and company voting rights
06/05/2026
(Article 223-16 of General Regulation of the French financial markets authority) PARIS, May 06, 2026 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the capital [...]
Alvotech Q1 2026 Financial Results
06/05/2026
Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental long ‑ form earnings release providing additional operational details and business update for Q1 2026 is available at: [...]
Bionano Announces Leadership Transition
06/05/2026
SAN DIEGO, May 06, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Al Luderer, Ph.D., chairman of Bionano’s Board of Directors, has been appointed interim president and chief [...]
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
06/05/2026
(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 06 mai 2026 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]
Gala Health Under Investigation: High-Quality Compounded GLP-1 Weight Loss & Hormone Therapy HRT Support
06/05/2026
Compounded Tirzepatide, Semaglutide, and Bioidentical HRT Telehealth Plans Through Gala GLP-1: Licensed Providers, $149/Mo Pricing, and All-50-States Access Explained for 2026 Wilmington, Delaware, May 06, 2026 (GLOBE [...]
Zelluna ASA activates first clinical site for ZIMA-101, marking entry into clinical execution
06/05/2026
Oslo, 6 May 2026 – Zelluna (OSE: ZLNA), a company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today announces that the first [...]
argenx to Present at BofA Securities 2026 Health Care Conference
06/05/2026
May 6, 2026 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that Karen [...]
BiomX’s Zorronet Puts Full AI Command-and-Control in the Palm of Your Hand
06/05/2026
Transforms fragmented communication into real-time, AI-driven coordination, assignment, and guided response NETANYA, Israel, May 06, 2026 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE: PHGE) (“BiomX” or the “Company”) today [...]
Supernus Pharmaceuticals to Participate in the Bank of America 2026 Health Care Conference
06/05/2026
ROCKVILLE, Md., May 06, 2026 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system [...]
Entrada Therapeutics to Announce Topline Results from Cohort 1 of Participants with Duchenne Muscular Dystrophy Treated with ENTR-601-44 in Phase 1/2 ELEVATE-44-201 Study on May 7, 2026
06/05/2026
BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) will announce topline results from Cohort 1 of the double-blind, placebo-controlled, multiple ascending dose portion of the Phase 1/2 [...]
Ultragenyx to Participate at Bank of America’s 2026 Healthcare Conference
06/05/2026
NOVATO, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra- [...]
Precision Optics Schedules Third Quarter of Fiscal Year 2026 Conference Call for May 13, 2026
06/05/2026
LITTLETON, Mass., May 06, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/ [...]

Pages